Theasaponin E1 was found to significantly reduce tau phosphorylation by suppressing and reducing the expression of genes and the activities of various kinases involved in hyperphosphorylation of tau proteins, which leads to the formation and aggregation of NFTs associated with Aβ production and AD pathogenesis. The gene discussed is MAPT; the disease is Alzheimer disease.